Rubius Therapeutics to Participate in Evercore ISI 4th Annual HealthCONx Conference
Rubius Therapeutics (Nasdaq: RUBY), a biopharmaceutical company specializing in Red Cell Therapeutics™, has announced that its CEO, Pablo J. Cagnoni, will join a fireside chat at the Evercore ISI 4th Annual HealthCONx Conference on November 30, 2021, at 10:55 a.m. EST. A live audio webcast will be accessible on the company's website, with a replay available for 90 days post-event. Rubius is focused on developing innovative treatments for cancer and autoimmune diseases using its proprietary RED PLATFORM®.
- None.
- None.
CAMBRIDGE, Mass., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™ for the treatment of cancer and autoimmune diseases, today announced that Pablo J. Cagnoni, M.D., President and Chief Executive Officer, will participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Conference on November 30, 2021, at 10:55 a.m. EST.
A live audio webcast will be available within the Investors & Media section of the Rubius Therapeutics website. An archived replay will be accessible for 90 days following the event.
About Rubius Therapeutics
Rubius Therapeutics is a clinical-stage biopharmaceutical company developing a new class of medicines called Red Cell Therapeutics™. The Company’s proprietary RED PLATFORM® was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent and off-the-shelf allogeneic cellular therapies for the potential treatment of several diseases across multiple therapeutic areas. Rubius’ initial focus is to advance RCT™ product candidates for the treatment of cancer and autoimmune diseases by leveraging two distinct therapeutic modalities — potent cell-cell interaction and tolerance induction. Rubius Therapeutics was named among the 2020 Top Places to Work in Massachusetts by the Boston Globe, and its manufacturing site was recently named 2021 Best Places to Work in Rhode Island by Providence Business News. For more information, visit www.rubiustx.com, follow us on Twitter or LinkedIn or like us on Facebook.
Contacts:
Investors
Elhan Webb, CFA, VP Investor Relations
elhan.webb@rubiustx.com
Media
Marissa Hanify, Director, Corporate Communications
marissa.hanify@rubiustx.com
FAQ
What is Rubius Therapeutics participating in on November 30, 2021?
Who is the CEO of Rubius Therapeutics?
What time is the Rubius Therapeutics event on November 30, 2021?
Where can I watch the Rubius Therapeutics webcast?
How long will the Rubius Therapeutics webcast be available for replay?
